Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers.
D000180:Acrylic Resins; D000269:Adhesives; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000465:Algorithms; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D005079:Excipients; D007700:Kinetics; D007785:Lactose / Q000031:analogs & derivatives*; D008747:Methylcellulose / Q000031:analogs & derivatives*; D009061:Mouth Mucosa / Q000378:metabolism*; D009391:Nephelometry and Turbidimetry; D010078:Oxazines; D011433:Propranolol / Q000008:administration & dosage*; D012995:Solubility; D013607:Tablets
D000180:Acrylic Resins; D000269:Adhesives; D000319:Adrenergic beta-Antagonists; D003692:Delayed-Action Preparations; D005079:Excipients; D010078:Oxazines; D013607:Tablets; C030312:calcium polycarbophil; D008747:Methylcellulose; C071191:MK 458; D011433:Propranolol; D007785:Lactose